Novo
Novo Nordisk
pharmaceutical industry · Bagsværd, Denmark
- PrincipalsLars Fruergaard JørgensenChief Executive OfficerMike DoustdarChief Executive Officer
- CompanyNovoBagsværd, Denmark
Danish pharmaceutical company. Industry: pharmaceutical industry. Produces: glucagon, insulin detemir, sex steroid, insulin aspart, liraglutide, glucagon-like peptide-1 agonist, recombinant factor VIIa, preproinsulin, Insulin degludec, turoctocog alfa, semaglutide, estradiol/norethisterone acetate.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. Wikidata industry: pharmaceutical industry; produces glucagon, insulin detemir, sex steroid, insulin aspart, liraglutide — Wikidata
People 2
Chief executive
Mike DoustdarChief Executive Officer
Supplier profile
- Production
- Yes
Products made 3
Source timeline
Record created from Wikidata
Wikidata ↗Lars Fruergaard Jørgensen — Chief Executive Officer
Wikidata ↗
Similar makers
Roivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityBeOne Medicines Ltd.Pharmaceutical Preparations · Basel1 shared capability